In this free webinar, learn how clinical trials and care
pathways are shifting to patients' homes — and oncology is no
exception. Attendees will gain insights into how, despite clear
benefits, incorporating digital health applications into oncology
treatments comes with unique challenges. The featured speaker will
discuss how high-volume data can be a blessing and a curse, and
therefore making the most of it requires converting it into
actionable insights. The speaker will also share how regulators
have a role to play in advancing digital health tools and
uptake.
TORONTO , Aug. 1, 2024
/PRNewswire-PRWeb/ -- Digital health tools and applications have
vast potential and applicability in the oncology care delivery
space. Yet, while the digital health market is expected to grow to
$221 billion by 2026 and cancer care
is estimated to cost the healthcare system approximately
$246 billion by 2030, digital health
solutions represent only about 3 percent of total oncology care
volume in oncology today, based on claims data.
The expansion of digital health
applications promises to not only improve patient outcomes but also
reduce costs and increase the efficiency of oncology care.
Against this backdrop, the opportunities for digital health
technologies to support cancer care on the provider side (via
screening, diagnosis, treatment decision support, prediction of
adverse events or clinical trial matching) and the patient side
(via patient-reported outcomes and experience measures), as well as
in terms of infrastructure and communication (via asynchronous
messaging between patients and providers), are enormous.
To successfully leverage these advancing technologies,
pharmaceutical and life science technology companies must come
together to develop tools that will arm providers with enhanced
screening, diagnosis, treatment and patient engagement. The
expansion of digital health applications promises to not only
improve patient outcomes but also reduce costs and increase the
efficiency of oncology care. As the market evolves, collaborating
to address barriers to technology adoption and regulatory
acceptance will be crucial in realizing the full potential of
digital health in oncology.
Register for this webinar today to learn how pharmaceutical and
life science technology companies are collaborating to harness
digital health tools in oncology care delivery.
Join Jaydev Thakkar, MBA, Chief
Operating Officer, Biofourmis, for the live webinar on Thursday, August 22, 2024, at 1pm EDT (10am
PDT).
For more information, or to register for this event, visit
Digital Health Tools That Will Transform Cancer Treatment.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading
provider of educational webinars and digital content to the global
life science, food, healthcare and medical device communities.
Every year, thousands of industry practitioners (from
pharmaceutical, biotechnology, food, healthcare and medical device
companies, private & academic research institutions, healthcare
centers, etc.) turn to Xtalks for access to quality content. Xtalks
helps professionals stay current with industry developments,
regulations and jobs. Xtalks webinars also provide perspectives on
key issues from top industry thought leaders and service
providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit
https://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com
Media Contact
Vera Kovacevic, Xtalks, +1 (416)
977-6555 x371, vkovacevic@xtalks.com, www.xtalks.com
View original content to download
multimedia:https://www.prweb.com/releases/digital-health-tools-that-will-transform-cancer-treatment-upcoming-webinar-hosted-by-xtalks-302211899.html
SOURCE Xtalks